Navigation Links
Vion Reports 2008 Third Quarter and Nine-Month Results
Date:11/3/2008

Quarterly Conference Call to be Held on Thursday November 6 at 8:30 a.m.

NEW HAVEN, Conn., Nov. 3 /PRNewswire-FirstCall/ -- VION PHARMACEUTICALS, INC. (OTC Bulletin Board: VION) today announced financial results for the three-month and nine-month periods ended September 30, 2008.

The Company reported a net loss of $6.8 million, or $0.92 per share, for the three-month period ended September 30, 2008, compared to a net loss of $9.0 million, or $1.33 per share, for the same period in 2007. Weighted-average common shares outstanding for the three months ended September 30, 2008 and 2007 were 7.4 million and 6.8 million, respectively.

Operating expenses were reduced by $3.0 million from $8.6 million in the third quarter of 2007 to $5.6 million in the comparable quarter in 2008. Interest expense for the three months ended September 30, 2008 and 2007 was $1.5 million and $1.4 million, respectively. Interest income for the three months ended September 30, 2008 and 2007 was $224,000 and $938,000, respectively.

For the nine-month period ended September 30, 2008, the net loss was $22.9 million, or $3.12 per share, compared to a net loss of $25.8 million, or $3.87 per share, for the same period in 2007. Weighted-average common shares outstanding for the nine months ended September 30, 2008 and 2007 were 7.4 million and 6.7 million, respectively.

Operating expenses were reduced by $5.7 million, from $25.1 million for the nine-month period in 2007, to $19.4 million in the comparable period in 2008. Interest expense related to the Company's Convertible Senior Notes issued in February 2007 increased by $887,000 over the prior year. Interest income for the first nine months of 2008 decreased by $1.6 million over the comparable 2007 period.

The Company reported ending the quarter with $42.8 million in cash and cash equivalents, sufficient to fund its operations through the fourth quarter of 2009 based on the current operating pla
'/>"/>

SOURCE Vion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008
2. Neovasc Reports Development Progress, Streamlined Operations and Issuance of Options
3. NxStage Reports Third Quarter 2008 Financial Results
4. Study reports Double Balloon Endoscopy useful for diagnosis and treatment of obscure GI bleeding
5. The Ensign Group, Inc. Reports Third Quarter 2008 Earnings; Reaffirms 2008 Guidance
6. Gen-Probe Reports Strong Financial Results for Third Quarter 2008, Raises Full-Year EPS Guidance
7. Poniard Pharmaceuticals Reports Third Quarter 2008 Financial Results and Corporate Update
8. Nuvelo Reports Third Quarter 2008 Financial Results
9. Claimsnet.com Reports Third Quarter 2008 Results
10. Remuda Ranch Reports Many Individuals With Eating Disorders Are Not Getting Help They Need
11. Palomar Medical Reports Financial Results for Third Quarter 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... A new $119 million industry is taking ... is redefining the way consumers get their seafood. ... culinary chefs on the Emerald Coast panhandle of Northwest ... and the promising industry of aquaculture. , The word ... strive to fully partake in the effort, especially when ...
(Date:6/18/2013)... As Mirena lawsuit claims continue to ... report has revealed that that the IUD has been the ... (FDA) adverse event reports since coming on the market in ... Mirena users have reported device dislocation or migration to the ... uterine perforations due to Mirena.* , “We are not at ...
(Date:6/18/2013)... New York magazine named 145 physicians from ... list, up from 129 last year and more than any ... lists 52 additional doctors who serve at hospitals within Mount ... The “Best Doctors” issue, which this year features a total ... and is available online at http://www.nymag.com/bestdoctors . , “America ...
(Date:6/18/2013)... 2013 -- Lauren Sciences, a privately-held biotechnology company ... technology, announced today that it was independently recognized ... its V-Smart Platform, and selected as a Featured ... , The report, " Early Stage ... Companies ," features companies MCD Group independently selected ...
(Date:6/18/2013)... more likely to keep their scheduled medical appointments ... their physician listens, explains things clearly and knows them ... Hopkins research suggests. , "If people feel their doctor ... that doctor has their best interests at heart and ... study leader Tabor E. Flickinger, M.D., M.P.H., a fellow ...
Breaking Medicine News(10 mins):Health News:New $119 Million Industry Swimming Up the East Coast 2Health News:Mirena Lawsuit News: Bernstein Liebhard LLP Comments on Mounting Reports of Mirena Side Effects, Including Device Migration, Uterine Perforations 2Health News:Mirena Lawsuit News: Bernstein Liebhard LLP Comments on Mounting Reports of Mirena Side Effects, Including Device Migration, Uterine Perforations 3Health News:Mount Sinai Tops the List in New York Magazine’s 2013 “Best Doctors” Issue 2Health News:Mount Sinai Tops the List in New York Magazine’s 2013 “Best Doctors” Issue 3Health News:Respect may be the key to stopping patient 'no shows' 2
... increased risk for life-threatening cardiovascular diseases, people with type ... advised to monitor their blood sugar levels more than ... study. ,Researchers conducted a meta-analysis of 13 previously ... sugar levels and cardiovascular disease. Results showed that blood ...
... of glycosylated hemoglobin, or HA1c, may be an independent ... // and stroke, according to the new research. Two ... control and the development of heart disease and stroke. ... people, investigators found a 21-percent increase in cardiovascular events ...
... tends to be more severe and resistant to medical ... improvement in symptoms when a full range of medical ... patients with asthma were found to have a higher ... compared to patients without asthma. A higher proportion of ...
... used antibiotic, but new research suggests it could be ... study shows patients should not be given erythromycin along ... because it increases the risk of sudden death. ... is any association between the use of erythromycin and ...
... designed to educate parents about allergens and tobacco smoke ... say researchers .More than 900 children with ... least one indoor environmental allergen and lived in low-income ... areas suffer from the disease at a disproportionately high ...
... to a recent study researchers say the antidepressant ... symptoms of fibromyalgia in women . Duloxetine ... // norepinephrine, two of the brain’s neurotransmitters that ... chronic musculoskeletal disorder that is characterized by body ...
Cached Medicine News:
(Date:6/18/2013)... June 18, 2013  Decision Resources, one of ... pharmaceutical and healthcare issues, announces that its Market ... Middle East and ... the challenges and opportunities to gaining and maintaining ... comprising 24 countries. The countries covered by Market ...
(Date:6/18/2013)... , June 18, 2013 Today, Wall ... (NASDAQ: GILD ), Health Management Associates Inc. (NYSE: ... IDXX ), ISIS Pharmaceuticals Inc. (NASDAQ: ISIS ), ... these reports free of charge - including full price targets, ... Gilead Sciences, Inc. Research Report On ...
(Date:6/18/2013)... , June 18, 2013  Pro football player ... and professional family expert Jo Frost ... Mylan Specialty L.P., the fully integrated specialty pharmaceutical business ... raise awareness of this significant health problem. In recognition ... Food and Drug Administration (FDA) approval of EpiPen ® ...
Breaking Medicine Technology:Decision Resources' Market Access Tracker Now Covers the Middle East and Africa 2Decision Resources' Market Access Tracker Now Covers the Middle East and Africa 3Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 2Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 3Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 4Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 5Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 6Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 2Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 3Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 4Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 5Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 6Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 7Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 8
... March 22 Royal Philips Electronics ( PHG, ... medical alert service.  This integrated solution offers an added ... medical alert service with automatic fall detection capabilities. Lifeline ... can automatically call for help if a fall is ...
... WALTHAM, Mass. , March 22 Interleukin Genetics, Inc. ... of the NYSE Amex LLC (the "Exchange") has granted the Company an ... Company will remain listed up to June 23, 2010 , subject ... progress towards the Company,s plan to regain compliance. , ...
Cached Medicine Technology:Philips Introduces Breakthrough Medical Alert Service That Helps Enable Continued Independence for Seniors by Improving Access to Help in the Event of a Fall 2Philips Introduces Breakthrough Medical Alert Service That Helps Enable Continued Independence for Seniors by Improving Access to Help in the Event of a Fall 3Philips Introduces Breakthrough Medical Alert Service That Helps Enable Continued Independence for Seniors by Improving Access to Help in the Event of a Fall 4Philips Introduces Breakthrough Medical Alert Service That Helps Enable Continued Independence for Seniors by Improving Access to Help in the Event of a Fall 5Philips Introduces Breakthrough Medical Alert Service That Helps Enable Continued Independence for Seniors by Improving Access to Help in the Event of a Fall 6NYSE Amex Provides Interleukin Genetics, Inc. Extension To Meet Continued Listing Standards 2NYSE Amex Provides Interleukin Genetics, Inc. Extension To Meet Continued Listing Standards 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: